Nuvectis Pharma (NVCT) Institutional Ownership $6.50 +0.15 (+2.36%) As of 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)CurrentInstitutional OwnershipPercentage96.77%Number ofInstitutional Buyers(last 12 months)24TotalInstitutional Inflows(last 12 months)$8.97MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$486.09K Get NVCT Insider Trade Alerts Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NVCT Institutional Buying and Selling by Quarter Nuvectis Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc15,000$112K0.0%N/A0.059% 8/15/2025 Bank of America Corp DE8,565$64K0.0%+417.2%0.034% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,029$53K0.0%N/A0.028% 8/13/2025 Marshall Wace LLP63,613$475K0.0%+63.6%0.250% 8/13/2025 New York State Common Retirement Fund13,000$97K0.0%N/A0.051% 8/12/2025 JPMorgan Chase & Co.6,263$47K0.0%+3,398.9%0.025% 8/8/2025 Police & Firemen s Retirement System of New Jersey3,785$28K0.0%N/A0.018% 8/8/2025 Austin Wealth Management LLC20,125$140K0.0%-50.0%0.096% 8/8/2025 Geode Capital Management LLC285,332$2.13M0.0%+110.8%1.366% 7/24/2025 Baldwin Wealth Partners LLC MA350,461$2.62M0.2%-2.2%1.678% Get the Latest News and Ratings for NVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. 6/27/2025 Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218% 5/19/2025 Jane Street Group LLC42,299$413K0.0%N/A0.202% 5/16/2025 Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218% 5/15/2025 OMERS ADMINISTRATION Corp32,882$321K0.0%N/A0.139% 5/1/2025 Austin Wealth Management LLC40,250$393K0.1%N/A0.172% 4/30/2025 Iridian Asset Management LLC CT253,972$2.48M0.8%N/A1.086% 4/23/2025 Oppenheimer & Co. Inc.41,000$401K0.0%+64.0%0.175% 4/14/2025 Baldwin Wealth Partners LLC MA358,461$3.50M0.2%+0.7%1.532% 4/11/2025 Blue Zone Wealth Advisors LLC10,424$102K0.0%N/A0.045% 2/17/2025 Squarepoint Ops LLC19,071$103K0.0%N/A0.099% 2/17/2025 Two Sigma Investments LP18,570$100K0.0%-30.7%0.096% 2/17/2025 Millennium Management LLC29,698$161K0.0%-56.6%0.154% 2/17/2025 Cubist Systematic Strategies LLC6,294$34K0.0%N/A0.033% 2/14/2025 Northern Trust Corp25,725$139K0.0%+68.7%0.133% 2/13/2025 Marshall Wace LLP124,571$674K0.0%+191.0%0.645% 2/12/2025 Edmond DE Rothschild Holding S.A.15,170$82K0.0%-20.9%0.079% 2/12/2025 Baxter Bros Inc.15,000$81K0.0%+20.0%0.078% 2/5/2025 Oppenheimer & Co. Inc.25,000$135K0.0%N/A0.129% 1/30/2025 Nations Financial Group Inc. IA ADV13,500$73K0.0%+35.0%0.070% 1/28/2025 Forbes J M & Co. LLP59,000$319K0.0%+21.9%0.305% 1/22/2025 Baldwin Wealth Partners LLC MA355,961$1.93M0.1%+104.4%1.842% 11/16/2024 Geode Capital Management LLC79,716$501K0.0%+49.8%0.413% 11/5/2024 GSA Capital Partners LLP50,129$315K0.0%+3.7%0.269% 11/5/2024 Nations Financial Group Inc. IA ADV10,000$63K0.0%N/A0.054% 10/25/2024 Iridian Asset Management LLC CT55,380$348K0.1%N/A0.297% 9/16/2024 Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050% 8/15/2024 Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050% 8/14/2024 Marshall Wace LLP33,868$214K0.0%-32.4%0.185% 8/9/2024 Renaissance Technologies LLC74,500$472K0.0%+20.7%0.406% 7/16/2024 Baxter Bros Inc.12,500$79K0.0%N/A0.068% 7/12/2024 Baldwin Brothers LLC MA168,630$1.07M0.1%+9.4%0.918% 5/10/2024 Vanguard Group Inc.298,800$2.45M0.0%+1.5%1.626% 4/18/2024 Blue Zone Wealth Advisors LLC14,350$118K0.0%N/A0.081% 2/12/2024 Edmond DE Rothschild Holding S.A.19,170$160K0.0%N/A0.111% 1/30/2024 Strs Ohio6,200$51K0.0%+59.0%0.036% 1/8/2024 Baldwin Brothers LLC MA142,040$1.19M0.1%+22.0%0.820% 11/2/2023 Forbes J M & Co. LLP34,000$438K0.1%-49.3%0.197% 10/26/2023 Strs Ohio3,900$50K0.0%+178.6%0.023% 10/10/2023 Baldwin Brothers LLC MA116,380$1.50M0.1%+29.2%0.675% 8/10/2023 Hollencrest Capital Management3,040$49K0.0%N/A0.019% 8/4/2023 American International Group Inc.3,298$53K0.0%N/A0.021% 8/3/2023 Forbes J M & Co. LLP67,000$1.07M0.1%N/A0.418% 8/2/2023 Bank of Montreal Can11,012$200K0.0%N/A0.069% 7/14/2023 Baldwin Brothers LLC MA90,061$1.44M0.1%-37.4%0.563% 5/11/2023 Edmond DE Rothschild Holding S.A.24,570$322K0.0%N/A0.167% 4/21/2023 Baldwin Brothers LLC MA143,800$1.89M0.2%+7.9%0.975% 11/4/2022Ronit Capital LLP562,547$3.99M5.4%+34.2%3.843% 10/14/2022 Baldwin Brothers LLC MA133,000$943K0.1%+9.9%0.908% 8/4/2022Ronit Capital LLP419,282$4.70M6.7%-23.8%3.297% 7/18/2022 Baldwin Brothers LLC MA121,000$1.36M0.2%N/A0.951% 5/11/2022Ronit Capital LLP550,000$4.08M5.1%N/A4.325% (Data available from 1/1/2016 forward) NVCT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NVCT shares? During the previous two years, 31 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were Baldwin Wealth Partners LLC MA ($2.62M), Iridian Asset Management LLC CT ($2.48M), Vanguard Group Inc. ($2.45M), Geode Capital Management LLC ($2.13M), Baldwin Brothers LLC MA ($1.07M), Marshall Wace LLP ($475K), and Renaissance Technologies LLC ($472K).Learn more on Nuvectis Pharma's institutional investors. What percentage of Nuvectis Pharma's stock is owned by institutional investors? 96.77% of Nuvectis Pharma's stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings. Which institutional investors have been buying Nuvectis Pharma's stock? Of the 29 institutional investors that purchased Nuvectis Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Iridian Asset Management LLC CT ($309.35K), Baldwin Wealth Partners LLC MA ($184.33K), Geode Capital Management LLC ($176.49K), Marshall Wace LLP ($106.50K), Goldman Sachs Group Inc. ($91.22K), Baldwin Brothers LLC MA ($66.48K), and Jane Street Group LLC ($42.30K). How much institutional buying is happening at Nuvectis Pharma? Institutional investors have bought a total of 1,159,974 shares in the last 24 months. This purchase volume represents approximately $8.97M in transactions. Which of Nuvectis Pharma's major shareholders have been selling company stock? The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Millennium Management LLC ($38.80K), Austin Wealth Management LLC ($20.13K), Two Sigma Investments LP ($8.22K), Baldwin Wealth Partners LLC MA ($8K), and Edmond DE Rothschild Holding S.A. ($4K). How much institutional selling is happening at Nuvectis Pharma? Institutional investors have sold a total of 79,141 shares in the last 24 months. This volume of shares sold represents approximately $486.09K in transactions. Related Companies ORGO Major Shareholders BCAX Major Shareholders RAPP Major Shareholders MAZE Major Shareholders RZLT Major Shareholders RLAY Major Shareholders IMTX Major Shareholders MRVI Major Shareholders KROS Major Shareholders TERN Major Shareholders This page (NASDAQ:NVCT) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersMusk Warns. Trump Acts. Your Retirement May Depend on ItWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVCT Stock Alerts